Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Theator is a private digital health company that develops an AI-powered surgical intelligence platform for the operating room. Its software captures and analyzes laparoscopic, robotic, and endoscopic surgical video, converts procedures into structured clinical data, and supports operative reporting, quality improvement, training, and patient safety workflows. The company markets products including its Surgical Intelligence Platform and Surgery-to-Text®, which auto-generates structured operative reports from video rather than dictation. Theator appears focused on health-system enterprise deployments rather than drug development, with adoption highlighted at institutions such as Mayo Clinic, Cleveland Clinic, and other North American health systems. The company is best characterized as a commercial-stage healthcare AI/software company rather than a biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Theator.